Curis (CRIS) Total Debt Growth (3y) (2015 - 2023)
Curis (CRIS) Total Debt Growth (3y) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.08% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.52% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -22.87% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -22.30% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.76% |
| 10 | Curis | 3.27 Mn | -2.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 114.89% |
| Mar 31, 2021 | -71.80% |
| Dec 31, 2020 | -72.58% |
| Sep 30, 2020 | -72.52% |
| Jun 30, 2020 | -65.84% |
| Dec 31, 2018 | 13.66% |
| Sep 30, 2018 | 13.27% |
| Jun 30, 2018 | 13.06% |
| Mar 31, 2018 | 13.23% |
| Dec 31, 2017 | 13.64% |
| Sep 30, 2017 | 13.79% |
| Jun 30, 2017 | -9.24% |
| Mar 31, 2017 | -10.17% |
| Dec 31, 2016 | -13.38% |
| Sep 30, 2016 | -11.96% |
| Jun 30, 2016 | -10.26% |
| Mar 31, 2016 | -8.80% |
| Dec 31, 2015 | -6.79% |